ASD-006 is an oral disease-modifying treat-ment (CoM pat. pend.) to prevent (progression of) age-related diseases, including  

- atherosclerosis/stroke (MACE)
- T2DM, NASH/NAFLD
- virus diseases (SARS-CoV) ...

ASD-006 modulates the endocytosis-lysosome-autophagy pathway by reducing serum phospholipids. The MoA of ASD-006 was established in several in vivo and clinical studies